Brief: Addex Announces Plan To Implement ADS Ratio Change
Oct 6 (Reuters) - Addex Therapeutics Ltd ADXN.S :
* ADDEX ANNOUNCES PLAN TO IMPLEMENT ADS RATIO CHANGE
* ADDEX THERAPEUTICS LTD - COMPANY ANTICIPATES THAT ADS
RATIO
CHANGE WILL BE EFFECTIVE ON OR ABOUT OCTOBER 23, 2023
* ADDEX THERAPEUTICS LTD: NEW ADS RATIO OF ONE (1) ADS TO
ONE
HUNDRED AND TWENTY (120) ORDINARY SHARES
Source text for Eikon: ID:nGNXDGDPb
Further company coverage: ADXN.S
((Reuters.briefs@thomsonreuters.com;))
Recent news on Addex Therapeutics
See all newsBrief: Addex Spin-Out Neurosterix Completes Phase 1 Clinical Studies Of NTX-253 For Schizophrenia
NASDAQ RESUMED AT 11:29 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:24 AM
Switzerland's Addex Therapeutics Q2 net loss narrows on decline in R&D expenses
Brief: Addex Therapeutics Q2 Operating Income CHF -645 Thousand